Back to PharmaIndex

Eurepa-V 1/0.2 Tablet

Repaglinide (1mg) + Voglibose (0.2mg)

Drug details

API

Repaglinide (1mg) + Voglibose (0.2mg)

Drug classification

Dosage form

API strength per dosage

Dose

Mechanism of action

Indications

Treatment of Type 2 diabetes mellitus

Side effects

Hypoglycemia low blood glucose level Abdominal pain Diarrhea Flatulence Upper respiratory tract infection Headache

Pregnancy category

Precautions

Contraindications

PharmaProLearn

Excel Beyond Limits